1. What Is the Oncology Pharmacy Market?
The Oncology Pharmacy Market covers specialty pharmacy dispensing, clinical pharmacy services, and pharmacy benefit management for oncology drugs including oral chemotherapy, targeted therapy, immunotherapy, and supportive care medications. Oncology pharmacy encompasses specialty pharmacy benefit management, oral oncology dispensing, pharmacy-oncologist care integration, and medication therapy management for cancer patients. Market dynamics reflect oral oncology drug share at 40 percent of cancer prescriptions, specialty pharmacy spend growth driving PBM oncology focus, and site-of-care transitions to specialty pharmacy dispensing.
2. Oncology Pharmacy Market Size & Forecast
3. Emerging Technologies
- Oral chemotherapy adherence monitoring platforms integrating pharmacy fill data with symptom reporting are advancing as patient management tools. Growing adoption at oncology specialty pharmacies is driven by oral oncology adherence improvement requirements.
- AI prior authorisation automation platforms reducing oral oncology therapy initiation delays are advancing as access tools. Growing adoption at oncology pharmacies is driven by therapy initiation wait time reduction requirements.
- Biosimilar oncology drug management platforms assisting with biosimilar conversion for monoclonal antibody therapies are advancing. Growing adoption at oncology practices is driven by chemotherapy cost management requirements.
- Digital prescription routing platforms optimising oral oncology dispensing site selection for adherence and cost are advancing. Growing adoption at oncology practices is driven by patient access and cost management requirements.
Similar technologies are also transforming adjacent markets. Learn more in our Cancer Registry Market.
4. Key Market Opportunity
The primary growth driver in the Oncology Pharmacy Market is the oral oncology specialty dispensing sub-market, where 40 percent oral drug share at USD 60,000 to 200,000 annual drug cost per patient creates large specialty pharmacy revenue per member. PBM oncology benefit management creates a recurring fee revenue channel as commercial payers manage escalating oncology drug spend. Physician office dispensing creates a practice revenue opportunity as oncology practices capture specialty pharmacy margin through in-office dispensing programmes. Asia Pacific oncology pharmacy creates geographic expansion as Japanese, Chinese, and South Korean oncology drug access programmes grow.
5. Top Companies in the Oncology Pharmacy Market
The following organisations hold leading positions in the Oncology Pharmacy Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- CVS Caremark (Specialty)
- Express Scripts (Accredo)
- Walgreens Specialty
- Coram CVS
- Diplomat Pharmacy (PharMerica)
- Biologics (Acentus)
- Tennessee Oncology (In-Office)
- McKesson Specialty
- AmerisourceBergen
- Kroll Specialty Pharmacy
6. Market Segmentation
The Oncology Pharmacy Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Drug Type | Oral Targeted Therapy Oral Chemotherapy Injectable Specialty Supportive Care |
| By Setting | Specialty Pharmacy Infusion Centre Hospital Outpatient Physician Office |
| By Service | Dispensing MTM Prior Auth Patient Assistance |
| By Geography | North America The U.S. Canada Europe The UK Germany France Italy Spain Denmark Netherlands Finland Sweden Norway Russia Austria Poland Rest of Europe Asia Pacific China Japan India South Korea Australia Indonesia Vietnam Philippines Singapore Taiwan Thailand Rest of Asia Pacific Latin America Brazil Mexico Argentina Rest of South America Middle East and Africa GCC Countries Israel South Africa Rest of Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Oncology Pharmacy Market trajectory over the forecast period:
CVS Health Specialty Pharmacy Achieves USD 60 Billion Annual Specialty Pharmacy Revenue With Oncology Segment.CVS Caremark specialty pharmacy achieving USD 60 billion annual specialty drug revenue in 2024 with 35 percent oncology drug share demonstrates oncology specialty pharmacy at commercial scale. CVS Specialty's 18,000 oncology patients under active pharmacy care management demonstrates clinical oncology pharmacy services at patient volume scale.
Express Scripts Accredo Oncology Specialty Pharmacy Achieves 25 Percent Market Share in US Oral Oncology.Express Scripts Accredo achieving 25 percent US oral oncology specialty pharmacy market share through insurance integration with Cigna commercial plans demonstrates PBM-pharmacy integration in oncology. Accredo's oral oncology adherence programme achieving 88 percent medication possession ratio demonstrates clinical pharmacy intervention improving oral chemotherapy adherence.
Physician Office Oral Oncology Dispensing Programmes Capture In-Office Pharmacy Revenue.Physician office dispensing of oral oncology through limited distribution programmes and 340B drug pricing enabling oncology practices to dispense oral chemotherapy in 2024 creates direct pharmacy revenue at treatment site. In-office dispensing achieving 95 percent medication initiation rate versus 75 percent at external pharmacy demonstrates the clinical adherence benefit of on-site oncology dispensing.
For related market intelligence, see the Lung Cancer Therapeutics Market.
8. Segmental Analysis
By drug type, the Oral Targeted Therapy segment dominated the Oncology Pharmacy Market in 2025. Representing the largest revenue category as EGFR inhibitors, KRAS inhibitors, and CDK4/6 inhibitors generate the largest oral oncology dispensing volume. The Injectable Specialty Pharmacy segment is the fastest-growing category, advancing as site-of-care transitions from infusion centres to home infusion specialty pharmacy drive revenue transfer.
By setting, the Specialty Pharmacy segment dominated the Oncology Pharmacy Market in 2025. Representing the largest setting revenue share. The Physician Office Dispensing segment is the fastest-growing setting category, advancing as clinical protocol standardisation and reimbursement expansion broaden market access. The Specialty Pharmacy structural position and Physician Office Dispensing growth momentum establish the core setting segmentation dynamic for the Oncology Pharmacy Market through 2034.
By service type, the Dispensing segment dominated the Oncology Pharmacy Market in 2025, as specialty pharmacy dispensing of oral oncolytics and injectable oncology drug delivery generates the majority of oncology pharmacy revenue. Prior Authorisation management is the fastest-growing service category, driven by payer utilisation management complexity and pharmaceutical hub service investment to reduce treatment delays for oncology patients.
9. Regional Analysis
Regional demand patterns across the Oncology Pharmacy Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Oncology Pharmacy Market in 2025, holding 53.8% of the global market. Retail and specialty oncology pharmacies, integrated health systems, and oncology benefit management companies are operating large-scale oral and infusion oncology drug dispensing, therapy management, and adherence monitoring programmes. Specialty pharmacy accreditation standards, payer oncology drug management requirements, and growing pharmaceutical hub services adoption for complex oncology therapies are encouraging oncology pharmacy infrastructure investment. High oncology drug spend, large specialty pharmacy network, and strong prescription volume generating demand for oncology pharmacy management platforms are generating dominant regional activity.
Highest CAGR Region
Europe is expected to register the highest CAGR of 10.43% during the forecast period. Hospital pharmacy departments, integrated cancer centre pharmacy operations, and oncology drug distribution organisations across Germany, France, the United Kingdom, and Italy are deploying oncology pharmacy management platforms to improve drug utilisation, reduce waste, and ensure treatment adherence. European Medicines Agency oncology drug approval activity and growing pharmaceutical investment in oral cancer therapies requiring pharmacy management are encouraging oncology pharmacy platform adoption. Rising oncology drug costs and increasing demand for clinical pharmacy oversight are generating European oncology pharmacy management demand.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Oncology Pharmacy Market was valued at USD 28.19 Bn in 2025 and is projected to reach USD 60.22 Bn by 2034, growing at a CAGR of 8.8% over the 2026–2034 forecast period.
The Oncology Pharmacy Market is projected to grow at a CAGR of 8.8% from 2026 to 2034.
North America accounted for the largest share of the Oncology Pharmacy Market in 2025, holding 53.8% of the global market.
The leading companies in the Oncology Pharmacy Market include CVS Caremark (Specialty), Express Scripts (Accredo), Walgreens Specialty, Coram CVS, Diplomat Pharmacy (PharMerica), Biologics (Acentus), Tennessee Oncology (In-Office), McKesson Specialty, AmerisourceBergen, Kroll Specialty Pharmacy.
Cvs health specialty pharmacy achieves usd 60 billion annual specialty pharmacy revenue with oncology segment.
By drug type, the Oral Targeted Therapy segment dominated the Oncology Pharmacy Market in 2025.
How to Order
Choose Your Package
Condensed edition of this study for students, researchers and academic institutions.
- Condensed edition of the full study
- For students, researchers & academic institutions
- Valid student ID or institutional email required
- Educational, non-commercial use only
The competitive landscape, including key market participants, company size, market positioning, and comparative competitive standing.
- 15 in-depth company profiles
- Company overview
- Product and brand portfolio mapped per company
- Revenue for the last 3 FYs with key financial metrics
- Segmental revenue and regional revenue breakdown
- Market presence, key geographies & end-use industries
- Recent developments
- Key capabilities, differentiators & strategic positioning
- SWOT Analysis
- 15-company market share analysis
- 2025 market share by company
- Company revenue in USD
- Competitive quadrant positioning
- Product portfolio comparison
The complete forecast model, including every study table, is provided in clean, formula-ready Excel format across 3 segmentation axes. Select the geographic coverage required for your analysis.
- One country, broken out across 3 segmentation axes
- 2025 base year, 2026–2034 forecast, CAGR per line
- Excel workbook
- Region totals plus every country inside that region
- All axes, all years, CAGR per line
- Cross-country comparison sheet included
- Excel workbook
- Every forecast table in the study
- Global, regional and country views in one workbook
- Segment share and CAGR pivots included
- Excel workbook
The full syndicated study. Every chapter, every region, every country, plus the complete Excel model, methodology and appendix.
- Executive summary, market scope & segmental snapshot
- Market dynamics: drivers, restraints, opportunities, challenges
- Quantitative analysis across 3 segmentation axes
- Regional analysis
- Competitive landscape, market share & company revenue mapping
- Includes the full Global Excel Data Pack
- Complete research methodology, assumptions & appendix
TAM/SAM/SOM sizing, M&A target screening, patent & IP analysis, supply-chain resilience mapping, ESG roadmaps and other bespoke strategic work.
- TAM / SAM / SOM sizing
- M&A target screening
- Patent & IP analysis
- Supply-chain resilience mapping
- ESG roadmaps & other bespoke strategic work
Not sure which package fits? Tell us the decision you are making and an analyst will recommend the smallest package that answers it. Talk to an analyst.
Ordering Process
Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.